Coley's Toxins - Availability

Availability

MBVax Bioscience, a Canadian Biotech company, produces Coley Fluid for research and clinical study. A private biotech company, Coley Pharmaceutical Group, has conducted clinical trials using genetic sequences which may have contributed to Coley's toxin's effectiveness, and was acquired by Pfizer in January 2008. In addition, the Waisbren Clinic in Wisconsin reports they have used Coley's toxin to treat patients since 1972. Coley's toxins are generally not available where approval or licence is required (in particular in the United States and Germany).

Drug makers including Pfizer and Sanofi-Aventis are interested in modern versions of Coley's toxins; Pfizer has acquired the Coley Pharmaceutical Group, set up in 1997

Read more about this topic:  Coley's Toxins

Famous quotes containing the word availability:

    Since ... six weeks ago, there has been no day in which I have not had letters and visits on the subject of my nomination for the Presidency.... I say very little. I have in no instance encouraged any one to work to that end.... I have said the whole talk about me is on the score of availability. Let availability do the work then.
    Rutherford Birchard Hayes (1822–1893)